Star-formation rate in compact star-forming galaxies

We use the data for the Hbeta emission-line, far-ultraviolet (FUV) and mid-infrared 22 micron continuum luminosities to estimate star formation rates averaged over the galaxy lifetime for a sample of about 14000 bursting compact star-forming galaxies (CSFGs) selected from the Data Release 12 (DR12) of the Sloan Digital Sky Survey (SDSS). The average coefficient linking and the star formation rate SFR_0 derived from the Hbeta luminosity at zero starburst age is found to be 0.04. We compare s with some commonly used SFRs which are derived adopting a continuous star formation during a period of ~100 Myr, and find that the latter ones are 2-3 times higher. It is shown that the relations between SFRs derived using a geometric mean of two star-formation indicators in the UV and IR ranges and reduced to zero starburst age have considerably lower dispersion compared to those with single star-formation indicators. We suggest that our relations for determination are more appropriate for CSFGs because they take into account a proper temporal evolution of their luminosities. On the other hand, we show that commonly used SFR relations can be applied for approximate estimation within a factor of ~2 of the averaged over the lifetime of the bursting compact galaxy.Comment: 11 pages, 7 figures, accepted for publication in Astrophysics and Space Scienc

Drug therapy for allergic rhinitis in children

Allergic rhinitis is characterized by increasing incidence and poses a medical and social problem. The article tells about current approaches to the treatment of allergic rhinitis. The use of Nasonex nasal corticosteroid in pediatric practice results in stable clinical improvement

Therapeutic and prevention potential of seawater medicines

The mucous membrane of the nasal cavity is the opening part of the respiratory tract which has a number of functions among which protection is the most important. Once in the nasal cavity, the inhaled air is mechanically cleaned of dust pollutants, humidified and warmed. About 10 thousand litres of air pass through the nose during a day. The nasal mucosa also hinders penetration of pathogens (bacteria, fungi, viruses) into the lungs

Mucolytic therapy of acute exacerbations of chronic rhinosinusitis

Epidemiologically acute and chronic inflammatory diseases of the mucous membranes of the nose and paranasal sinuses (PNS) are among the most common pathologies. Sinusitis is one of the most common reasons for seeking doctor's aid in developed countries. Patients with rhinosinusitis account for 15 to 36% of all hospitalized patients in ENT units [1, 2]. Rhinosinusitis accounts for an even greater percentage of all respiratory diseases in outpatient settings

The study of the efficacy and safety of Tonsilgon® N in the treatment of chronic pharyngitis

Chronic pharyngitis is one of the most common diseases in ENT practice. [1] Experts have not yet come to a consensus on how to treat chronic pharyngitis. The search for combination drugs which are effective in the treatment of chronic pharyngitis is determined, first, by an attempt to prevent polypharmacy and complications caused by treatment, and, second, by the problem of antibiotic resistance. The role of medications with combined action, including the immunomodulating effect, cannot be overestimated. One of the most commonly used drugs today is Tonsilgon® N (Bionorica SE, Germany). [2

Use of herbal medicines in the treatment of children with acute sinusitis

Acute inflammation of the paranasal sinuses (PNS) is one of the urgent problems in pediatric otolaryngology. Despite the introduction of new methods of diagnosis and treatment, the prevalence of acute sinusitis has not decreased today; just on the opposite, the number of patients tends to increase, particularly among children. The incidence of acute sinusitis in the past ten years has doubled, while the proportion of hospitalized patients grows annually by 1.5-2%. Among patients seeking ENT care at healthcare facilities, those with diseases of PNS constitute the majority and account for 62% [1]

Pharyngomycosis. Diagnostics, prevention and treatment

The prevalence of pharyngomycosis was analysed on the basis of research data and own observation of 2,987 patients seeking assistance in the consulting unit of the Centre over the period from 2008 till 2011. The study concluded that the proportion of fungal infections of ENT organs in the total variety of chronic inflammatory disease increased to 29% for fungal infections of the throat in pharyngitis, and to 17.2% in chronic tonsillitis. The pathogens of fungal infections of the throat were defined and analyzed. The study found that the involvement of Candida non albicans strains in the development of chronic inflammation has increased. The proportion of cases of aspergillus infection of the mucous membranes of the pharynx, larynx, and tonsils was identified. Sophisticated diagnosis and treatment schemes were suggested